Eran Bar-Meir1, Eduard Fridman, Isaac Zilinsky, Arie Orenstein, Eyal Winkler. 1. Department of Plastic and Reconstructive Surgery, Chaim Sheba Medical Center, Tel Hashomer, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. eranbarmeir@yahoo.com
Abstract
BACKGROUND: Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare tumor presenting as a painless subcutaneous mass in the extremities first reported in 1998. We report the first case of a MIFS tumor in the groin. METHODS: We have performed seven immunohistochemical stains that were not applied before on MIFS. RESULTS: The first case of a MIFS tumor in the groin. CONCLUSIONS: MIFS must be considered in the differential diagnosis of a painless mass not only in the distal extremities but also in the groin. The diagnosis of this tumor is difficult and can be missed if not considered because of the unusual location. Due to high recurrence rates and one case of documented metastases, the recommended treatment is wide excision.
BACKGROUND: Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare tumor presenting as a painless subcutaneous mass in the extremities first reported in 1998. We report the first case of a MIFS tumor in the groin. METHODS: We have performed seven immunohistochemical stains that were not applied before on MIFS. RESULTS: The first case of a MIFS tumor in the groin. CONCLUSIONS: MIFS must be considered in the differential diagnosis of a painless mass not only in the distal extremities but also in the groin. The diagnosis of this tumor is difficult and can be missed if not considered because of the unusual location. Due to high recurrence rates and one case of documented metastases, the recommended treatment is wide excision.
Authors: Raffaele Lombardi; Elio Jovine; Nicola Zanini; Maria Cristina Salone; Marco Gambarotti; Alberto Righi; Alba Balladelli; Marco Colangeli; Michele Rocca Journal: Int Orthop Date: 2013-09-06 Impact factor: 3.075